Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Hyalex MTP Study

NCT: NCT07538141 · ACTIVE_NOT_RECRUITING

NCT IDNCT07538141
StatusACTIVE_NOT_RECRUITING
Start Date2025-10-01
Completion2027-05-31
SponsorHyalex Orthopaedics, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The HYALEX SLALOM MTP Hemiarthroplasty System consists of a synthetic implant designed to replace the distal metatarsal surface of the great toe for treatment of arthritis . The system is composed of the HYALEX MTP Implant and instrumentation. The implant consists of the HYALEX Cartilage material bonded to a titanium backing.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑